Cite

HARVARD Citation

    Zhang, L. et al. (2022). An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS‐CoV‐2. EMBO molecular medicine. 14 (11), p. n/a. [Online]. 
  
Back to record